Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Challenges to the development of personalised medicine
Prof Alexander Eggermont – President of the European Academy of Cancer Sciences;...
Challenges to the development of personalised medicine ( Prof Alexander Eggermont – President of the European Academy of Cancer Sciences; Prof Franҫoise Meunier – Director General, EORTC )
22 Oct 2012
Progress of personalised oncology treatment
Prof Martine Piccart – President-Elect of ECCO
Progress of personalised oncology treatment ( Prof Martine Piccart – President-Elect of ECCO )
22 Oct 2012
Role of ECCO in the development of personalised oncology treatment
Kathy Oliver – ECCO Patient Advisory Committee; Prof Julio Celis – ECCO Policy C...
Role of ECCO in the development of personalised oncology treatment ( Kathy Oliver – ECCO Patient Advisory Committee; Prof Julio Celis – ECCO Policy Committee; Prof Cornelis van de Velde – President of ECCO )
22 Oct 2012
Developing technologies for personalised treatment
Dr Atanasio Pandiella – Instituto de Biologia Molecular y Celular del Cancer, Sa...
Developing technologies for personalised treatment ( Dr Atanasio Pandiella – Instituto de Biologia Molecular y Celular del Cancer, Salamanca, Spain )
12 Oct 2012
Development and expansion of the IFOM-IEO campus
Prof Marco Foiani – University of Milan, Italy and Scientific Director IFOM
Development and expansion of the IFOM-IEO campus ( Prof Marco Foiani – University of Milan, Italy and Scientific Director IFOM )
9 Oct 2012
Histology and non-histology driven therapy for soft tissue sarcomas and the Rare...
Dr Paolo Casali – Instituto Nazionale Tumori, Milan, Italy
Histology and non-histology driven therapy for soft tissue sarcomas and the Rare Cancers Europe initiative ( Dr Paolo Casali – Instituto Nazionale Tumori, Milan, Italy )
9 Oct 2012
Improving health outcomes around the world
Catharine Grimes – Director, Bristol-Myers Squibb Foundation
Improving health outcomes around the world ( Catharine Grimes – Director, Bristol-Myers Squibb Foundation )
20 Sep 2012
Translational and tailored, but can we afford it?
Prof Gordon McVie - European Institute of Oncology and ecancer
Translational and tailored, but can we afford it? ( Prof Gordon McVie - European Institute of Oncology and ecancer )
17 Jul 2012
Translational and tailored, but can we afford it?
Prof Ulrik Ringborg - Karolinska Institute, Stockholm, Sweden
Translational and tailored, but can we afford it? ( Prof Ulrik Ringborg - Karolinska Institute, Stockholm, Sweden )
17 Jul 2012
The changing field of drug development
Dr Jonathan Yingling – Oncology Drug Discovery, Eli Lilly
The changing field of drug development ( Dr Jonathan Yingling – Oncology Drug Discovery, Eli Lilly )
16 Jul 2012
Important to support young medical oncologists’ research
Prof Roberto Labianca – Riuniti Hospital, Bergamo, Italy
Important to support young medical oncologists’ research  ( Prof Roberto Labianca – Riuniti Hospital, Bergamo, Italy )
16 Jul 2012
The WINTHER study
Prof Razelle Kurzrock - MD Anderson Cancer Center, Houston, USA
The WINTHER study ( Prof Razelle Kurzrock - MD Anderson Cancer Center, Houston, USA )
16 Jul 2012